Michael S. Toss
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ
Toss, Michael S.; Miligy, Islam M.; Gorringe, Kylie L.; Mittal, Karuna; Green, Andrew R.; Aneja, Ritu; Ellis, Ian O.; Rakha, Emad A.
Authors
Islam M. Miligy
Kylie L. Gorringe
Karuna Mittal
Dr Andy Green ANDREW.GREEN@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Ritu Aneja
Ian O. Ellis
Professor EMAD RAKHA Emad.Rakha@nottingham.ac.uk
PROFESSOR OF BREAST CANCER PATHOLOGY
Abstract
Aims: Cathepsin V (CTSV/CTSL2) is a lysosomal cystine proteinase and plays a role in extracellular matrix degradation. It is associated with poor prognosis in invasive breast cancer (IBC), but its role in breast ductal carcinoma in situ (DCIS) remains unclear. In this study, we aimed to evaluate the prognostic significance of CTSV in DCIS.
Methods: CTSV protein expression was immunohistochemically assessed in a well characterised and annotated cohort of DCIS comprising, pure DCIS (n=776) and DCIS coexisting with IBC (n=239). CTSV expression was analysed in tumour cells and surrounding stroma, including its association with clinicopathological parameters and outcome.
Results: In pure DCIS, high CTSV expression was observed in 29% of epithelial tumour cells and 20% of surrounding stroma. High expression in both components was associated with features of poor prognosis including higher nuclear grade, hormone receptor negativity and HER2 positivity. In addition, stromal CTSV expression was associated with larger DCIS size, comedo type necrosis and high proliferation index. DCIS associated with IBC showed higher CTSV expression than pure DCIS either within the epithelial tumour cells or surrounding stroma (p
Citation
Toss, M. S., Miligy, I. M., Gorringe, K. L., Mittal, K., Green, A. R., Aneja, R., Ellis, I. O., & Rakha, E. A. (2020). Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ. Journal of Clinical Pathology, 73(2), 76-82. https://doi.org/10.1136/jclinpath-2019-205939
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 10, 2019 |
Online Publication Date | Aug 23, 2019 |
Publication Date | 2020-02 |
Deposit Date | Aug 12, 2019 |
Journal | Journal of Clinical Pathology |
Print ISSN | 0021-9746 |
Electronic ISSN | 1472-4146 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 73 |
Issue | 2 |
Pages | 76-82 |
DOI | https://doi.org/10.1136/jclinpath-2019-205939 |
Keywords | DCIS; proteolysis; CTSV; stroma; recurrence |
Public URL | https://nottingham-repository.worktribe.com/output/2419685 |
Publisher URL | https://jcp.bmj.com/content/early/2019/08/22/jclinpath-2019-205939 |
Additional Information | This article has been accepted for publication in Journal of Clinical Pathology following peer review, and the Version of Record can be accessed online at http://dx.doi.org/10.1136/jclinpath-2019-205939 © Authors (or their employer(s)) |
You might also like
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Epitranscriptomic mechanisms of androgen signalling and prostate cancer
(2024)
Journal Article
Stromal lymphocytes are associated with upgrade of B3 breast lesions
(2024)
Journal Article
The characteristics and prognostic significance of histone H1 expression in breast cancer
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search